MedPath

Effectiveness and safety of nebulized budesonide in controlling acute wheezing in under three-year-olds who are unresponsive to fenoterol

Not Applicable
Completed
Conditions
Wheezing in children
Respiratory
Registration Number
ISRCTN21515674
Lead Sponsor
The University of Medicine of Botucatu (UNESP) (Brazil)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
75
Inclusion Criteria

1. Children from 1 month to 3 years old
2. Moderate to very severe acute wheezing, defined by a modified Wood clinical score over 3 after three doses of fenoterol at 20 minute intervals

Exclusion Criteria

1. Previous use of systemic corticosteroid
2. Inhalation of corticosteroid or topical corticosteroid in the past 10 days
3. Cardiopathy
4. Nephropathy
5. Neuropathy
6. Inadequate nutritional level

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath